Rolland
Y, Abellan Van Kan G, Benetos A, Blain H, Bonnefoy M, Chassagne P, Jeandel C,
Laroche M, Nourhashémi F, Orcel P, Piette F, Ribot C, Ritz P, Roux C, Taillandier
J, Tremollieres F, Weryha G, Vellas B. Frailty, osteoporosis and hip fracture:
causes, consequences and therapeutic perspectives. J Nutr Health Aging. 2008;12(5):335-46
Trémollieres
FA, Pouillès JM, Laparra J, Ribot C. Bone mineral density at menopause
does not predict breast cancer incidence. Osteoporos Int. 2008 Mar 29. [Epub ahead
of print]
Ribot
C, Trémollieres F, Pouillés JM. Aromatase and regulation of bone
remodeling. Joint Bone Spine. 2006;73(1):37-42. Epub 2005 Aug 1
Pouillès
JM, Trémollieres FA, Ribot C. Osteoporosis in otherwise healthy perimenopausal
and early postmenopausal women: physical and biochemical characteristics. Osteoporos
Int. 2006;17(2):193-200. Epub 2005 Jul 15
Trémollieres
FA, Bauvin E, Cigagna F, Pouillès JM, Cauneille C, Arnaud C, Ribot C. Association
of cardiovascular risk factors with intima-media thickness of the carotid arteries
in early postmenopausal women. Menopause. 2004;11(3):323-30
Pouilles
JM, Ribot C, Trémollières F. Is absorptiometry useful for monitoring
osteoporosis treatment? Joint Bone Spine. 2001 Oct;68(5):367-9
Trémollieres
FA, Pouilles JM, Ribot C. Withdrawal of hormone replacement therapy is associated
with significant vertebral bone loss in postmenopausal women. Osteoporos Int.
2001;12(5):385-90
Pouillès
JM, Tremollières FA, Martinez S, Delsol M, Ribot C. Ability of peripheral
DXA measurements of the forearm to predict low axial bone mineral density at menopause.
Osteoporos Int. 2001;12(1):71-6
Trémollières
F. [Alternatives to hormonal treatment for the prevention of postmenopausal osteoporosis:
the bisphosphonates] Gynecol Obstet Fertil. 2001;29(11):846-52
Pouilles JM, Ribot C, Trémollières F. Is absorptiometry useful for monitoring
osteoporosis treatment? Joint Bone Spine. 2001;68(5):367-9
Trémollières
FA, Pouilles JM, Ribot C. Withdrawal of hormone replacement therapy is associated
with significant vertebral bone loss in postmenopausal women. Osteoporos Int.
2001;12(5):385-90
Pouilles
JM, Trémollières FA, Martinez S, Delsol M, Ribot C. Ability of peripheral DXA
measurements of the forearm to predict low axial bone mineral density at menopause.
Osteoporos Int. 2001;12(1):71-6
Ribot
C, Trémollières F, Pouilles JM. [Estrogens and selective estrogen receptor modulators
in the treatment of osteoporosis] Ann Med Interne (Paris). 2000;151(6):490-6.
Trémollières
FA, Cigagna F, Alquier C, Cauneille C, Pouilles J, Ribot C. Effect of hormone
replacement therapy on age-related increase in carotid artery intima-media thickness
in postmenopausal women. Atherosclerosis. 2000;153(1):81-8
Pouilles
JM, Collard P, Trémollières F, Frayssinet P, Railhac JJ, Cahuzac JP, Autefage
A, Ribot C. Accuracy and precision of in vivo bone mineral measurements in sheep
using dual-energy X-ray absorptiometry. Calcif Tissue Int. 2000;66(1):70-3
Trémollières
F, Ribot C. [Hormone replacement therapy in the prevention of osteoporosis. Evolution
of therapeutic methods] Presse Med. 1999;28(22):1188-94.
Trémollières
FA, Pouilles JM, Cauneille C, Ribot C. Coronary heart disease risk factors and
menopause: a study in 1684 women. Atherosclerosis. 1999;142(2):415-23
Trémollières
F. [Can osteoporosis be prevented with low doses of estrogen?] J Gynecol Obstet
Biol Reprod (Paris). 1998;27 Suppl 1:8-11
Ribot C, Trémollières F. Estrogens and osteoporosis. Rev Rhum Engl Ed. 1998;65(11):641-8
Tricoire
J, Rolland M, Trémollières F, Ribot C. [Value of bone mineral content measurement
in preterm infants given corticosteroids for bronchopulmonary dysplasia] Arch
Pediatr. 1998;5(6):697-9
Ribot
CA, Trémollières FA. Effect of estrogens on bone and other systems and hormonal
substitute treatment. Curr Opin Rheumatol. 1997;9(4):362-9
Pouilles
JM, Trémollières F, Roux C, Sebert JL, Alexandre C, Goldberg D, Treves R, Khalifa
P, Duntze P, Horlait S, Delmas P, Kuntz D. Effects of cyclical etidronate therapy
on bone loss in early postmenopausal women who are not undergoing hormonal replacement
therapy. Osteoporos Int. 1997;7(3):213-8
Trémollières
FA, Pouilles JM, Ribot CA. Relative influence of age and menopause on total and
regional body composition changes in postmenopausal women. Am J Obstet Gynecol.
1996;175(6):1594-600
Jamrozik
SI, Bennet AP, James-Deidier A, Trémollières F, Saint-Martin F, Dumoulin S, Valat-Coustols
M, de Glisezinski I, Tremoulet M, Manelfe C, Louvet JP. Treatment with long acting
repeatable bromocriptine (Parlodel-LAR*) in patients with macroprolactinomas:
long-term study in 29 patients. J Endocrinol Invest. 1996;19(7):472-9
Pouilles JM, Trémollières F, Ribot C. [Vertebral bone loss in perimenopause. Results
of a 7-year longitudinal study] Presse Med. 1996;25(7):277-80
Pouilles
JM, Trémollières F, Ribot C. Variability of vertebral and femoral postmenopausal
bone loss: a longitudinal study. Osteoporos Int. 1996;6(4):320-4
Pouilles
JM, Trémollières F, Ribot C. Effect of menopause on femoral and vertebral bone
loss. J Bone Miner Res. 1995;10(10):1531-6
Ribot
C, Pouilles JM, Trémollières F. Should we define osteoporosis based on bone mineral
density criteria? Rev Rhum Engl Ed. 1995;62(9):546-8
Ã
retour
